Archives for April 2008
Tracleer (Bosentan) Receives New Indication In Patients With Systemic Sclerosis And Active Digital Ulcer Disease
Actelion Pharmaceuticals UK Ltd announced that Tracleer® (bosentan), a dual endothelin receptor antagonist, has been approved in the UK and Ireland for the reduction of the number of new digital ulcers (DUs) in patients with systemic sclerosis (SSc) and ongoing DU disease.1DUs are a frequent, extremely painful and disabling complication of SSc2, caused by [...]
Lip Balms And Glosses May Raise Skin Cancer Risk
If you are a regular lip balm or lip gloss user you should perhaps bear in mind that there is a good chance your risk of developing skin cancer is greater, according to researcher, Dr. Christine Brown, Baylor University Medical Center, Dallas. The balms/glosses actually attract the ultraviolet rays. Not only do we [...]
Delcath Expands Phase III Trial For Metastatic Melanoma To Include University Of Maryland Medical Center
Delcath Systems, Inc. (Nasdaq: DCTH) announced that the Institutional Review Board (IRB) of the University of Maryland Medical Center (UMMC) has approved UMMC’s participation in the Phase III study of the Company’s Percutaneous Hepatic Perfusion (PHP) System for the isolated, high dose delivery of the anti-cancer agent melphalan to treat inoperable metastatic melanoma in [...]
Aeolus Pharmaceuticals’ AEOL 10150 Provides Significant Protection Of Lungs And Skin In Animal Studies Of Mustard Gas Exposure
Aeolus Pharmaceuticals, Inc. (OTC Bulletin Board: AOLS) reported that researchers from National Jewish Research and Medical Center and the University of Colorado have completed a series of studies demonstrating that AEOL 10150 provides statistically significant protection of the lungs and skin in the 2-chloroethyl-ethylsulfide (CEES; half mustard) model of mustard gas exposure in rats.
Original post [...]
Revolutionary Genetic Test For Women’s Hair Loss Launched
HairDX, LLC (http://www.hairdx.com) pioneers of consumer-friendly genetic tests for hair loss, today introduced the first meaningful test using genetic markers strongly associated with Female Hair Loss (Female Androgenetic Alopecia). The easy to understand test provides an accurate and understandable genetic analysis of a woman’s likelihood of developing this common type of hair loss.
Original post by [...]
Scalp And Neck Melanoma Survival
“Skin cancers on the scalp or neck are more deadly than those elsewhere on the body, a large study has suggested”, BBC News reported. The Daily Telegraph also describes the results of a new study that examined the prognosis (chance of survival) of patients who developed a malignant melanoma on their scalp or neck.
Original [...]
FDA Clears Glove Made From New Type Of Latex
The U.S. Food and Drug Administration has cleared for marketing the first device made from a new form of natural rubber latex, guayule latex. The product, the Yulex Patient Examination Glove, is derived from the guayule bush, a desert plant native to the Southwestern United States.Traditional latex gloves are made from the milky sap of [...]
Sensitive Skin A Symptom Of Migraine
“Migraine hurts skin” is the headline in the Daily Mirror. The newspaper describes the symptom of sensitive skin, called allodynia, where sufferers of migraine find combing their hair, wearing jewellery or getting dressed “excruciatingly painful”. The newspaper reports that 10% of people in the UK suffer migraine. The Daily Telegraph covers the same story [...]
Baby Friendly Bacteria Can Help Prevent Development Of Eczema
Eczema is a distressing condition for both parents and babies - the raw, red skin is painful to see and it is difficult to stop small children from scratching it. At worst, it can mean having to wet wrap wriggly toddlers each day with bandages soaked in moisturisers. It usually starts in the first year [...]
BioVex Agrees SPA With The FDA For A Pivotal Study With OncoVEX(GM-CSF) In Metastatic Melanoma And Announces Presentation Of Phase II Results At ASCO
BioVex Inc, a biotechnology company developing clinical stage treatments for cancer and the prevention of infectious disease, announced that the U.S. Food and Drug Administration (FDA) has approved the design of a single, pivotal, Phase III clinical trial evaluating its lead product, OncoVEX(GM-CSF) in previously treated patients with metastatic melanoma. The agreement was made [...]